US Approves First Daily Obesity Pill: Wegovy Oral
US regulators approve first daily oral weight-loss drug, Wegovy pill, expanding treatment options. Novo Nordisk gains edge in obesity market race. Read the full story.
US regulators approve first daily oral weight-loss drug, Wegovy pill, expanding treatment options. Novo Nordisk gains edge in obesity market race. Read the full story.
Experts reveal the key pitfalls that cause weight regain after stopping GLP-1 medications like Ozempic and Wegovy, and how to maintain your results long-term.
Emily Butler, 26, spent two weeks fighting for her life after a severe reaction to progesterone tablets triggered a rare blood condition. Discover her story and the vital warning about medication risks.
Danish pharmaceutical giant Novo Nordisk has cut its sales and profit forecasts for the second time in three months, sending shockwaves through the healthcare sector as demand for its blockbuster weight-loss drugs shows signs of slowing.
Great British Bake Off star Dame Prue Leith reveals her dramatic change of heart about weight loss injections, warning they're not the miracle solution many believe.